Published in Br J Cancer on March 01, 1990
Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma. PLoS One (2015) 0.77
Natural killer and lymphokine activated killer cell functions in Hodgkin's disease. Br J Cancer (1990) 0.75
T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol (1978) 28.92
The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med (1987) 3.66
High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells. J Exp Med (1986) 2.37
Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor. J Exp Med (1987) 2.15
Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor. J Exp Med (1987) 1.57
Retention of biological activity following radioiodination of human interleukin 2: comparison with biosynthetically labeled growth factor in receptor binding assays. J Immunol Methods (1985) 1.27
Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease. Br J Cancer (1984) 1.00
Hodgkin's disease: biology, treatment, prognosis. Blood (1981) 0.99
Comparison of the biological activities of human recombinant interleukin-2(125) and native interleukin-2. J Biol Response Mod (1985) 0.96
Effect of age on the human high affinity interleukin 2 receptor of phytohaemagglutinin stimulated peripheral blood lymphocytes. Clin Exp Immunol (1989) 0.93
Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease. Cancer (1976) 0.93
Demonstration of inhibitory factors affecting cell-mediated immunity in patients with Hodgkin's disease. Eur J Cancer (1980) 0.88
Impairment of T lymphocyte colony formation in Hodgkin's disease: effect of soluble inhibitory factors on normal T lymphocyte colony formation potential. Acta Haematol (1983) 0.86
Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease. Eur J Cancer Clin Oncol (1985) 0.85
Effect of exogenous interleukins on in vitro responses of T lymphocytes from patients with Hodgkin disease. Cancer Detect Prev (1987) 0.84
The immune derangement in Hodgkin's disease. Semin Hematol (1985) 0.84
Lymphoid subpopulations of peripheral blood and spleen in untreated Hodgkin's disease. Cancer (1981) 0.84
Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease. Br J Cancer (1987) 0.84
Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease. Clin Immunol Immunopathol (1985) 0.84
Distribution of subpopulations of T lymphocytes in Hodgkin's disease. Neoplasma (1985) 0.82
Production of interleukin-2 and expression of tac antigen in Hodgkin disease. Cancer Detect Prev Suppl (1987) 0.81
Association of an interleukin abnormality with the T cell defect in Hodgkin's disease. Blood (1984) 0.80
Safe and efficacious use of procedural sedation and analgesia by non-anesthesiologists in a pediatric hematology-oncology unit. Indian Pediatr (2006) 2.78
Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci U S A (1989) 1.86
PMN cells from chronic myeloid leukemia (CML) patients show defective chemotaxis in remission. Leuk Res (1989) 1.42
2-CdA in the treatment of hairy cell leukaemia. J Assoc Physicians India (2001) 1.39
Antilymphocyte globulin (ALG) or antithymocyte globulin (ATG) with methylprednisone and oxymethalone in aplastic anaemia. J Assoc Physicians India (1997) 1.38
Malignant lymphoma and coexistent tuberculous lymphadenitis. J Assoc Physicians India (1991) 1.08
Distribution of beta-thalassemia mutations in the Indian population referred to a diagnostic center. Hemoglobin (2000) 1.05
A study of 1126 leukaemia cases--epidemiologic and end result analysis. Indian J Cancer (1979) 1.03
First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study. Ann Oncol (2005) 1.03
Myelomatous pleural effusion. J Assoc Physicians India (2006) 0.95
Oral cancers in Mumbai, India: a fifteen years perspective with respect to incidence trend and cumulative risk. Asian Pac J Cancer Prev (2004) 0.95
Retinoblastoma: problems and perspectives from India. Pediatr Hematol Oncol (1999) 0.93
Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: impact on pathogenesis. Ann Oncol (2000) 0.93
Pulmonary microsporidial infection in a patient with CML undergoing allogeneic marrow transplant. Bone Marrow Transplant (1997) 0.92
A constitutive relationship for large deformation finite element modeling of brain tissue. J Biomech Eng (1995) 0.92
Guidelines for treatment of recurrent or metastatic head and neck cancer. Indian J Cancer (2014) 0.89
All-trans-retinoic acid (ATRA): pediatric acute promyelocytic leukemia. Pediatr Hematol Oncol (1998) 0.88
A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin. Cancer (1988) 0.88
Primary lymphoma of bone: experience of 39 cases at the Tata Memorial Hospital, India. J Surg Oncol (1990) 0.88
Survival of childhood acute lymphoblastic leukemia: results of therapy at Tata Memorial Hospital, Bombay, India. Leuk Lymphoma (1996) 0.88
Demonstration of inhibitory factors affecting cell-mediated immunity in patients with Hodgkin's disease. Eur J Cancer (1980) 0.88
Pediatric oncology in India. Indian J Pediatr (1988) 0.87
Demonstration of cellular immunity in chronic myeloid leukaemia using leucocyte migration inhibition assay. Br J Cancer (1976) 0.87
Epithelial ovarian cancer following cure of cervical carcinoma (a case report). J Postgrad Med (1989) 0.86
Establishment and characterization of four new squamous cell carcinoma cell lines derived from oral tumors. J Cancer Res Clin Oncol (1990) 0.86
L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol (1999) 0.86
Impairment of T lymphocyte colony formation in Hodgkin's disease: effect of soluble inhibitory factors on normal T lymphocyte colony formation potential. Acta Haematol (1983) 0.86
Urinary bladder cancer following cyclophosphamide therapy for Hodgkin's disease. Leuk Lymphoma (1992) 0.86
Blood viscosity parameter correlation with types of leukemia. Physiol Chem Phys Med NMR (1992) 0.86
Elevation of serum polyamines in malignant lymphomas and acute myeloid leukemia. Int J Cancer (1980) 0.86
Extramedullary blast crisis in chronic myeloid leukaemia simulating lymphoma. Indian J Cancer (1977) 0.85
Evaluation of leukemia specific immunity in chronic myeloid leukemia. Haematologica (1977) 0.85
Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients. J Clin Lab Immunol (1989) 0.85
Natural killer and lymphokine-activated killer cell functions in chronic myeloid leukemia. Cancer Immunol Immunother (1990) 0.85
Expression of Fas and Fas ligand in Hodgkin's disease. Leuk Lymphoma (1999) 0.84
Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease. Br J Cancer (1987) 0.84
Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol (2000) 0.84
Primary non-Hodgkin's lymphoma of the spleen presenting as space occupying lesion: a case report and review of literature. Leuk Lymphoma (2006) 0.84
Effect of exogenous interleukins on in vitro responses of T lymphocytes from patients with Hodgkin disease. Cancer Detect Prev (1987) 0.84
Clinical and phenotypic heterogeneity in L3-acute lymphoblastic leukaemia. Indian J Cancer (1988) 0.83
Testicular dysfunction after cyclophosphamide-vincristine-procarbazine-prednisolone chemotherapy for advanced Hodgkin's disease. A long-term follow-up study. Cancer (1990) 0.83
Anterior chemotherapy in esophageal cancer. Cancer (1985) 0.83
Acute promyelocytic leukemia with ischaemic events. J Assoc Physicians India (1993) 0.83
Low incidence of CNS relapse with cranial radiotherapy and intrathecal methotrexate in acute lymphoblastic leukemia. Indian Pediatr (1996) 0.83
Infection analysis in acute lymphoblastic leukemia: a report of 499 consecutive episodes in India. Pediatr Hematol Oncol (1994) 0.82
Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens. Br J Cancer (1979) 0.82
Ewing's sarcoma. J Surg Oncol (1993) 0.82
Premature separation of centromere and aneuploidy: an indicator of high risk in unaffected individuals from familial breast cancer families? Eur J Cancer Prev (1996) 0.82
Pattern of subtypes of acute lymphoblastic leukemia in India. Leuk Res (1985) 0.82
Disparate cleavage of poly-(ADP-ribose)-polymerase (PARP) and a synthetic tetrapeptide, DEVD, by apoptotic cells. Apoptosis (2001) 0.82
Effect of activated charcoal on the pharmacokinetics of high-dose methotrexate. Cancer Treat Rep (1982) 0.82
Chromosomal characteristics of chronic and blastic phase of chronic myeloid leukemia. A study of 100 patients in India. Cancer Genet Cytogenet (1991) 0.82
Profile of ABH & I antigens in leukaemia. Indian J Med Res (1986) 0.82
In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia. Br J Cancer (1981) 0.82
Giant cell fibroblastoma. J Surg Oncol (1993) 0.82
Activation of HHV-6 in lymphoproliferative disorders: a polymerase chain reaction-based study. Ann N Y Acad Sci (2004) 0.82
Distribution of subpopulations of T lymphocytes in Hodgkin's disease. Neoplasma (1985) 0.82
Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7. Cancer Genet Cytogenet (2001) 0.81
Management of Hodgkin's disease in western India. Cancer (1984) 0.81
Safety profile of single-dose dexamethasone premedication for paclitaxel. J Clin Oncol (1996) 0.81
Gonadal function following ABVD therapy for Hodgkin's disease. Am J Clin Oncol (1997) 0.81
A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma. Cancer (1998) 0.81
Treatment of Askin Rosai tumor--need for a more aggressive approach. J Surg Oncol (1988) 0.81
Hepatitis B vaccination in acute lymphoblastic leukemia. Leuk Res (1998) 0.81
Production of interleukin-2 and expression of tac antigen in Hodgkin disease. Cancer Detect Prev Suppl (1987) 0.81
Results of allogeneic bone marrow transplant in chronic myeloid leukaemia following conditioning with busulfan and cyclophosphamide. J Assoc Physicians India (1999) 0.80
Acute nonlymphoblastic leukemia in the first of three siblings affected with Fanconi's syndrome. Am J Pediatr Hematol Oncol (1986) 0.80
Defective chemotaxis and adherence in granulocytes from chronic myeloid leukemia (CML) patients. Leuk Res (1985) 0.80
Characterization of the H-2 antigens of L-M mouse cells grown in culture. J Natl Cancer Inst (1966) 0.80
Acute lymphoblastic leukemia in childhood: treatment, results and prognostic factors. Indian J Cancer (1989) 0.80
T-cell acute lymphoblastic leukemia: a report of 60 patients from India. Oncology (1985) 0.80
Functional activities of enriched Fc receptor bearing T lymphocytes in Hodgkin's disease. Oncology (1986) 0.80
Karyotypic findings as an independent prognostic marker in chronic myeloid leukaemia blast crisis. Leuk Res (1994) 0.80
In vivo elastic modulus of the left ventricle: its determination by means of a left ventricular vibrational model and its physiological significance and clinical utility. Med Biol Eng (1975) 0.80
Non-Hodgkin's lymphomas in children, clinical histological and treatment analysis. Indian J Cancer (1987) 0.80
L-asparaginase related hyperglycemia. Indian J Cancer (1993) 0.80
Poland's syndrome with acute lymphoblastic leukemia in an adult. Med Pediatr Oncol (1988) 0.80
Circulating immune complexes in Hodgkin's disease. Reactivity of IgG isolated from circulating immune complexes. Neoplasma (1993) 0.79
Disseminated blastomycosis--a case report. Indian J Pathol Microbiol (1988) 0.79
Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implications. Leuk Lymphoma (2002) 0.79
Treatment results of Hodgkin's disease in Indian children. Pediatr Hematol Oncol (1996) 0.79
Nasopharyngeal carcinoma in India: end-result analysis (1980-1984). J Surg Oncol (1988) 0.79
Preliminary experience with allogeneic bone marrow transplantation in haematological disorders in India. J Assoc Physicians India (1990) 0.79
Cytochemical and immunophenotypic heterogeneity in acute promyelocytic leukemia. Acta Haematol (1989) 0.79
Calla positive acute lymphoblastic leukemia after etoposide-based therapy for Ewing's sarcoma. Leuk Res (1995) 0.79